SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,428.95 -210.08
( -0.27%)

Global Indices

Nasdaq

53,210.99 704.96
(1.34%)

Dow Jones

7,621.51 110.79
(1.48%)

Hang Seng

63,983.92 229.02
(0.36%)

Nikkei 225

10,850.37 -17.68
(-0.16%)

Forex

USD-INR

95.40 -0.19
(-0.20%)

EUR-INR

110.00 0.21
(0.19%)

GBP-INR

128.60 0.50
(0.39%)

JPY-INR

0.61 0.01
(2.47%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sanofi India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500674

INE058A01010

325.3278333

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SANOFI

23.71

7795.19

EPS(TTM)

Face Value()

Div & Yield %

142.76

3.63

Back

Sanofi India standalone net profit declines 14.14% in the March 2026 quarter

Apr 29,2026

Net profit of Sanofi India declined 14.14% to Rs 102.60 crore in the quarter ended March 2026 as against Rs 119.50 crore during the previous quarter ended March 2025. Sales declined 11.87% to Rs 472.30 crore in the quarter ended March 2026 as against Rs 535.90 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	472.30	535.90	-12
OPM %	30.24	32.08	-
PBDT	146.90	174.90	-16
PBT	137.90	165.30	-17
NP	102.60	119.50	-14

78,428.95 -210.08 ( -0.27%)

53,210.99 704.96 (1.34%)

7,621.51 110.79 (1.48%)

63,983.92 229.02 (0.36%)

10,850.37 -17.68 (-0.16%)

95.40 -0.19 (-0.20%)

110.00 0.21 (0.19%)

128.60 0.50 (0.39%)

0.61 0.01 (2.47%)